Corvus Pharmaceuticals, Inc. (CRVS) Q2 2026 Earnings Call Transcript

Corvus Pharmaceuticals NASDAQ: CRVS reported a wider second-quarter loss as it increased spending on

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.19) per share which missed the analyst

Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PT

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT Company to host conference ca

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS - Get Free Report) were up 5.1% during mid-day

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

David Scott Moore acquired 21,700 common shares for a transaction value of approximately $250,000 on

SOUTH SAN FRANCISCO, Calif. , June 09, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq

Corvus Pharmaceuticals, Inc. (CRVS) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen

SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:

Corvus Pharmaceuticals, Inc. remains a Sell as its valuation has run ahead of fundamentals following

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer

Corvus Pharmaceuticals, Inc. (CRVS) Shareholder/Analyst Call Transcript

New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to inc

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive dat

SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq

Two oral presentations including late-breaker at SID  Data will cover Phase 1 clinical trial of soqu

Stocks traded higher with Dow Jones up by 1,000 points. Consumer discretionary shares rose while ene

The Dow Jones index rose 700 points, Autoliv Inc (NYSE: ALV) reported strong results causing a jump

Shares of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS - Get Free Report) have been given a consensus

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS - Get Free Report)'s stock price fell 6.5% during trading

Corvus Pharmaceuticals, Inc. (CRVS) Q4 2025 Earnings Call Transcript

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a pro

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

  Wednesday's session saw 361 companies set new 52-week lows.

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc

  On Tuesday, 951 companies hit new 52-week lows.

  On Wednesday, 215 companies set new 52-week lows.